Navigation Links
PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
Date:10/29/2008

Middle, MB ChB, Corporate Vice President and Worldwide Head of Clinical Pharmacology at PAREXEL. "We are honored to receive this award in partnership with Glenmark from GCPj, which recognizes the in-depth expertise that PAREXEL brings to bear to help clients identify and select the most promising compounds, and make better and faster go/no-go decisions."

The early phase development program included evaluating the safety, tolerability, pharmacokinetic, and pharmacodynamic effects in healthy volunteers in single and multiple ascending dose Phase I studies. The Phase I studies were followed by a Proof of Concept study in 60 patients with Type II diabetes. The multi-site program used three of PAREXEL's Clinical Pharmacology Research Units in London, England, and in Bloemfontein and George, South Africa. Global patient recruitment strategies and the combined protocol developed by PAREXEL and Glenmark contributed to accelerating development timelines and exceeding milestone targets. Results included enabling Glenmark to make a go/no-go decision seven months earlier and complete the program 30 percent faster than is typical during early phase drug development.

For more information about PAREXEL's early phase development capabilities visit: http://www.parexel.com/early_phase.html.

The Good Clinical Practice Journal Awards Ceremony was held October 22, 2008 at the Banqueting House in London. Additional information about the awards and winners can be found at http://www.gcpjawards.com. Good Clinical Practice Journal (GCPj) (http://www.gcpj.com) addresses the regulatory, strategic, and clinical issues that directly impact clinical studies globally.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, provi
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
4. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
5. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
7. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
8. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
9. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
10. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
11. PAREXEL International Announces 2-For-1 Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015 Tianyin Pharmaceutical Inc. (NYSE ... in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... the Company,s Annual Meeting of Shareholders for fiscal year ... held at the Company,s office located in ... 9:00 AM (local time in Chengdu, China ...
(Date:5/26/2015)... 26, 2015 Pharmaco-Kinesis Corporation (PKC) announced today ... at Shutters on the Beach in Santa ... of the Company,s innovative Metronomic Biofeedback Pump (MBP), a ... chemotherapy over time to a target site of the ... biofeedback system in real-time.  ...
(Date:5/26/2015)... May 26, 2015 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral ... the study protocol for the company,s Phase IIb trial ... Food and Drug Administration (FDA). The submission was made ... The Phase IIb study of ORMD-0801 for ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Just the ... a long-standing unmet biomedical need does not guarantee immediate ... problem that has seen many prior failures is often ... acceptance and use is an irony that is often ... small, new start-up company, Asymmetrex has found ...
Breaking Biology Technology:TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 2Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 4Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 5Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 2In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 3
... Jan. 13 /PRNewswire-Asia-FirstCall/ -- Genesis,Pharmaceuticals Enterprises, Inc. ... a U.S. pharmaceutical company with its principal ... announced that it engaged KPMG Huazhen,("KPMG"), a ... independent member firms,affiliated with KPMG International, to ...
... Johnston Blakely & Company, LLC, a,Boston-based life ... Michael,D. Webb has joined the firm as senior ... with the firm on internal and client-related activities ... placements, with a,particular focus on biopharmaceutical transactions. ...
... 1:00PM PTNEW YORK, Jan. 13 Keryx Biopharmaceuticals, Inc. ... S. Weiss, the Company,s Chairman and Chief Executive Officer, ... Annual Healthcare Conference being held in San Francisco.Mr. Weiss, ... at 1:00pm PT and will be accessible from the ...
Cached Biology Technology:Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program 2Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program 3Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference 2
(Date:5/22/2015)... OXFORD, CT , May 22, 2015  NXT-ID, Inc. ... from June 1st, it will be ending its promotional pricing ... www.wocketwallet.com . Laurence Savin , Head of ... our exclusive promotional pricing until the end of May. To ... at wocketwallet.com/invite and when we open the store on June ...
(Date:5/20/2015)... , May 20, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the addition ... the Global Iris Recognition Market"  report ... , ,This research service analyses trends ... the government and commercial sectors, globally. ...
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... The USDA,s National Institute of Food and Agriculture ... for humanitarian assistance programs. "The United States is ... people around the world who are suffering during emergency ... of Food and Agriculture (NIFA). "These projects will improve ...
... cycle created when an obese individual overeats to compensate ... fewer pleasure receptors and overeat to compensate, according to ... research fellow and Oregon Research Institute senior scientist Eric ... The Journal of Neuroscience . Stice shows evidence ...
... Plant biologists have been making groundbreaking advances in ... including discoveries that will help lead to improvements in ... Now two of the nation,s largest private sponsors ... support for some of the country,s most innovative plant ...
Cached Biology News:Research examines vicious cycle of overeating and obesity 2ASPB applauds HHMI and GBMF for launching plant science program 2ASPB applauds HHMI and GBMF for launching plant science program 3
... The complete SSCP kit provides all the ... detection by single-stranded conformation polymorphism analysis (SSCP) ... The kit includes a cooling finger adaptor ... provided), 2 sets of 20 cm plates, ...
...
...
...
Biology Products: